SIOR Broker Survey Reflects Confidence in Office, Industrial Markets

With headlines like “Sublease Space Approaching Record Levels” showing up almost daily in the news feeds of those in the commercial real estate industry, it would be easy to conclude that the office market is on the verge of collapse.

However, a recent survey by the Society of Industrial and Office Realtors (SIOR) tells a different story.

While not overly optimistic regarding the state of office sales and leasing, the September edition of the organization’s monthly “Snapshot Sentiment Survey” shows that the market is slowly and steadily improving as the world continues to grapple with the impact of COVID-19 on the economy.

When SIOR released its initial report in April, the outlook for the market was decidedly grim. The more than 500 respondents to the survey (from both office and industrial sectors across the globe) conveyed that 31.6 percent of transactions had been put on hold by clients, and an additional 17.1 percent of deals had been canceled outright. Only 26.1 percent of transactions had been completed on schedule, with third parties constituting an additional 25.1 percent of delays. The percentage of delays and cancellations for office were slightly higher, while the industrial sector was correspondingly lower.

By September, when asked what had changed for in-progress transactions in the past month, the percentage was 56.7 (more than doubled from April) while the number of transactions put on hold (16.2 percent) or canceled outright (8.1 percent) have been halved.

While those numbers in, and of, themselves are not exactly cause for rejoicing, they paint a rosier picture than that of unfiltered Q3 leasing reports. By tracking the data during the entire course of the pandemic, SIOR members, who need to be active as commercial real estate brokers for five years while achieving demonstrated track records of success, have been able to provide a “boots-on-the-ground” perspective on leasing and sales activity.

“There’s a lack of velocity for deals being done right now but, at the same time, there’s a lot of discussions about transactions,” said SIOR member Jeff Deitrick, executive vice president for Pittsburgh-based Oxford Realty Services. “If you look at our production numbers, yeah, they’re down, but they’re not down drastically. Corporations are taking a ‘wait and see attitude’, but I see that going away once a vaccine is found, we’re past the elections, and people understand what the path is moving forward.”

Continue Reading at Commercial Observer

Medical marijuana sales soar amid COVID-19, making Pa. one of the nation’s fastest growing cannabis markets

During the last six months, the size of Pennsylvania’s medical marijuana program has surged due to the anxiety-producing effects of COVID-19 and some favorable changes to regulation.

The number of patient visits at cannabis dispensaries has risen by more than 70 percent — rising from 70,000 a week in February to 120,000 each week in August.

Retail sales also have exploded. Since February, dispensaries have sold as much marijuana as they had during the previous two years combined, according to statistics released last week by the state Department of Health, which governs the cannabis program.

Patients bought about $385 million in legal marijuana products from the state’s 89 cannabis dispensaries during the period, according to the state Office of Medical Marijuana. Until February, total retail sales since the inception of the highly regulated industry two years ago in the Keystone State had totaled only about $400 million. There are at least 27 dispensaries now operating in the five-county region.

“The program is doing really well,” said Chris Woods, CEO of Terrapin Care Station, a cannabis grower and processor upstate in Clinton County. “It’s hard not to draw a correlation with COVID-19. In unsettled times, cannabis is a medicine that seems to help people cope with anxiety.”

Anxiety remains one of the most cited reasons for getting a state medical marijuana card. It comes in second only to chronic pain. Post traumatic stress disorder is a distant third.

Why has marijuana suddenly taken off?

It is chiefly attributable to temporary changes to the regulations implemented by the Wolf administration. Marijuana dispensaries were among the first businesses deemed “essential” by Gov. Tom Wolf. But Wolf also streamlined access to medical marijuana in ways that made it safer to join the program.

Continue Reading at MSN.com

Flurry of Investor Interest in Arizona Sparked by Prospect of Recreational Marijuana Legalization

Investors and cannabis companies are jockeying for a stake in Arizona’s $750 million-plus marijuana market in advance of a likely adult-use legalization ballot initiative in November.

If, as expected, residents vote to legalize adult use, the recreational program could launch by next spring.

The rec initiative – which favors existing medical marijuana operators – is creating enormous interest among investors despite the recession and tight capital markets, according to industry insiders.

While the election sets up the prospect of multimillion-dollar medical marijuana license sales, it’s unclear how many businesses will decide to cash out given that the initiative gives existing operators the inside track to what is expected to be a massive rec opportunity.

“We will have adult use, the marketplace will double in size and an Arizona license is going to be one of the best investments” going, said Demitri Downing, founder of the Arizona Marijuana Industry Trade Association (MITA) and a cannabis consultant.

A business’ ability to qualify for an adult-use license immediately increases the value of an operation by 30%-80% because of the additional market opportunities, Downing estimated.

Arizona cannabis attorney Janet Jackim said marijuana companies and investors, both in-state and from other regions, “are trying to gobble up any licenses they can.”

In fact, she said she already is working on several potential transactions.

Continue Reading at Marijuana Business Daily

Coronavirus Could Accelerate US Cannabis Legalization

As the economic damage from the coronavirus pandemic piles up, U.S. cities and states are set to face significant lost revenue given the loss of business activity.

But, as DataTrek Research’s Jessica Rabe writes in a note, “there’s a simple and effective solution for states and cities to help cover their huge budget shortfalls after the COVID-19 pandemic subsides: legalize recreational sales of marijuana.”

New York, the epicenter of COVID-19 cases in the U.S., might see a revenue drop of $4 billion to $7 billion compared to what it was expecting, according to the state comptroller. With a budget of $87.9 billion, that’s significant.

11 states and Washington, D.C. currently allow legal recreational cannabis. (Yahoo Finance)
11 states and Washington, D.C. currently allow legal recreational cannabis. (Yahoo Finance)

“We’ve been thinking a lot about how life will change post-virus, and one big difference will be that state and local governments are going to encounter large unexpected tax receipt shortages,” Rabe wrote. “That’s particularly true when it comes to sales and income taxes amid stressed consumer balance sheets and massive layoffs. And unlike the Federal government, states can’t print unlimited amounts of money.”

Legalization of cannabis for adults, Rabe points out, could be a really easy way to shore up tax basis without driving people out of state, as raising income tax might do. Already it has been successful at raising “hundreds of millions of dollars annually in states like Colorado,” she said. There are currently 11 states with legalized recreational cannabis and another 15 that have decriminalized the drug in one way or another.

Continue Reading at Yahoo.com

Dow Drops 1,400 Points and Tumbles into a Bear Market

The coronavirus-induced sell-off reached a new low on Wednesday as Wall Street grappled with the rapid spread of the virus as well as uncertainty around a fiscal response to curb slower economic growth resulting from the outbreak.

The Dow Jones Industrial Average tumbled 1,464.94 points, or 5.9%, to close at 23,553.22. The 30-stock average closed in a bear market, down more than 20% below the record close set only last month and putting to end an expansion that started in 2009 amid the financial crisis.

The S&P 500 ended the day 4.9% lower at 2,741.38 and just short of a bear market. The Nasdaq Composite fell 4.7% to 7,952.05 and was also about 19% below its all-time high. A 20% decline is considered a bear market on Wall Street. However, most investors don’t recognize it officially until an index does it on a closing basis.

“We can see the panic in the equity market,” said Jerry Braakman, chief investment officer of First American Trust. “The big question for most people is, are we at the bottom yet? I think we’re only about halfway there.”

Losses intensified on Wednesday after the World Health Organization declared the outbreak an official global pandemic. The number of coronavirus cases around the world totaled more than 100,000, according to data from Johns Hopkins University. In the U.S. alone, more than 1,000 cases have been confirmed. This increase in cases added to fears of a global economic slowdown and have increased calls for government intervention.

Continue reading at CNBC.com

Illinois Sells $1 Million in Legal Cannabis—Per Day

Just two months into adult-use legalization and Illinois dispensaries are selling more than a million dollars of legal cannabis—per day.

‘Today marks another milestone in the successful launch of Illinois’ legal cannabis industry.’

Toi Hutchinson, senior advisor, Governor Pritzker for cannabis control

That number is based off revenue from steep taxes on legal sales. The state reported $10 million in cannabis tax revenue for the month of January, Gov. JB Pritzker’s office reported Feb. 24. The report shows how legalization is off to a roaring start in the Land of Lincoln.

Robust marijuana sales started Jan. 1, 2020 to tens of thousands of state residents and tourists who braved freezing pre-dawn temperatures and hours-long lines to smoke a piece of state history.

Long lines continued for days as flowers and vapes supplies quickly ran low. Some stores closed to recreational consumers, but kept serving medical patients. The result? Over $39 million in taxed, tested cannabis transactions; instead of street sales. Those sales generated $7.3 million in cannabis tax revenue, plus $3.1 million in retail sales tax revenue for the month of January.

‘Successful launch’

After taxes pay for regulators, the revenue goes to communities impacted by the war on drugs, as well as anti-drug programs, and mental health programs. Illinois built on the work from 10 prior legalization states, said Toi Hutchinson, senior advisor to Governor Pritzker for cannabis control.

“Today marks another milestone in the successful launch of Illinois’ legal cannabis industry. Our goal has been to build the nation’s most socially equitable program that includes new opportunities for the communities most harmed by the failed war on drugs. Revenue raised in this first month will soon begin flowing back into those communities to begin repairing the damage done by the failed policies of the past and creating new opportunities for those who have been left behind for far too long,” said Hutchinson.

Continue reading at Leafly.com

Pursuing Alpha: Private Equity Opportunities in the Decade Ahead

From Manulife Investment Management

Key takeaways

  • Private equity capital has become a more prominent source for financing global commercial enterprise, and returns on that capital, less tied to beta than those from public markets, have helped raise the profile of private equity investing as an asset class around the world.
  • We see five ways in which private equity investing can continue to play a positive role in the years ahead, contributing to the betterment of investors, businesses, employees, pensioners, and economies across the globe.

Our economy is moving away from public companies

Amsterdam’s Stock Exchange was founded in 1602, and the Dutch East India Company was the world’s first listed public company.¹ While the number of stocks trading on public exchanges around the globe increased over the next four centuries, fewer companies are going public these days. There were 486 U.S. initial public offerings during 1999, but only 190 such offerings in 2018.² In fact, the total number of listed U.S. companies has fallen by over 40% since the late 1990s.³

Fewer companies are going public these days

Number of U.S. publicly listed companies, 1980-2018
Number of U.S. publicly listed companies, 1980–2018 The chart shows that the total number of listed U.S. companies has fallen by over 40% since peaking at over 8,000 in the late 1990s.

Source: Cerulli, 2019.

 

Meanwhile, the number of private equity-backed companies is on the rise and now dwarfs the number of companies listed on U.S. public equity exchanges—a trend that’s indicative of what’s happening around the world. Globally, there were 9,000 private equity deals done in 2018, compared with just 1,700 in 2001.⁴ The growth of private equity assets under management has been brisk, too, especially in Asia, which now accounts for one-quarter of the global private equity market.⁵

 

U.S. private equity-backed companies now outnumber listed companies

U.S. private equity-backed companies now outnumber listed equities The table shows that the total number of U.S. private equity-backed companies has doubled between 2006 and 2017 while the number of U.S. publicly traded companies has declined.

Source: McKinsey, 2019.

 

 

Unlike a typical public equity shareholder, who has no influence on how a corporation is run, private equity funds often take controlling positions in portfolio companies and become actively involved in setting the strategic direction of these companies. Board control ultimately represents an owner’s call option on management regime change. Even if the owner never has cause to exercise the option, the arrangement tends to align executive teams’ interests with those of the business owners, encouraging all involved to focus exclusively on the opportunities and risks most crucial to the long-term success or failure of the business. Whereas their publicly traded counterparts are frequently plagued by distraction and Wall Street’s fixation on short-term results, well-run private equity-backed companies tend to benefit from an incentive structure and timeline that encourages a management team to deploy its best thinking and energies on the two or three most meaningful objectives likely to drive long-term value creation. Private equity is about pairing talented investors with exceptional management teams and using their collective wisdom to get the job done together.

 

Private equity assets have more than doubled in less than a decade

Global private equity assets, 2009-2Q 2018 ($U.S. billions)
Global private equity assets, 2009 to mid 2018 ($US billions) The chart shows that global private equity assets have climbed to over $3.4 trillion as of mid 2018, up from less than $1.6 trillion at the end of 2009.

Source: Cerulli, 2019.

 

There are a number of factors behind the shift from public to private capital, yet we can point to two changes in U.S. law that played a role in a multi-year trend that continues today. The Sarbanes-Oxley Act of 2002, for example, a response to the wave of accounting fraud scandals epitomized by Enron’s collapse, made reporting requirements for U.S. public companies more onerous than they had been before. A decade later, the U.S. Jumpstart Our Business Startups (JOBS) Act, a different type of law designed to address a different problem, allowed private companies to have up to 2,000 shareholders (an increase from only 500) before being required to disclose their results. Both Sarbanes-Oxley and JOBS had unintended knock-on effects, providing less incentive for companies to go public and more incentive for them to remain in, or return to, private hands. It’s particularly true for capital-light, R&D-intensive firms that wish to keep their proprietary intellectual capital out of view of competitors and the public spotlight alike. And the global economy is seemingly shifting such that most companies now see their intangible assets as more important than their tangible assets.⁶

“Private equity is about pairing talented investors with exceptional management teams and using their collective wisdom to get the job done together.”

 

Global central banks have also helped fuel the transition in recent years, as low interest rates have made it easier for private equity investors to transact with borrowed funds. More than a decade after the depths of the global financial crisis, policy rates remain at or near record lows around the world, and an abundance of relatively cheap debt with issuer-friendly terms is still available to finance acquisitions.

The intersection of private equity and alpha

While legislative, macroeconomic, and monetary policy developments have helped private equity capital become a more prominent source for financing global commercial enterprise, the returns on that capital have helped raise the profile of private equity as an investment asset class around the world.

Some of the most sophisticated institutional investors have been shifting portfolio allocations toward private equity and away from public equities for years. For example, the dollar-weighted average allocation of all U.S. higher education endowments to private equity more than tripled (from 3% to 10%) between 2002 and 2018, while the allocation to domestic public equities declined by over half (from 37% to 16%) during that period.⁷ Today, roughly 60% of private equity investors are university endowments, charitable foundations, and employee pension funds.⁸

“… private equity may still represent the brightest light in a dimming universe of investment prospects hampered by today’s high asset valuations and low yields.”

 

So far, the allocation shift toward private equity has worked out in favor of these institutions and their beneficiaries. Global private equity net asset value has grown by a factor of 7½ since 2002, compared with a 3½-fold increase in public equities’ market capitalization over the same period.⁴ Following this impressive outperformance run, private equity may still represent the brightest light in a dimming universe of investment prospects hampered by today’s high asset valuations and low yields. The reason is that, relative to listed public equities, regression analysis reveals that private equity performance has been driven more by alpha and less by beta, “and equally as important, is that alpha is generally less correlated than beta.”⁹

Private equity is driven less by beta and more by alpha

Alpha and beta vs. MSCI ACWI (Gross USD), 2000-2018¹⁰
Alpha and beta vs. MSCI All Country World Index (gross USD), 2000–2018 This chart shows the global private equity data captured by Cambridge Associates has had a long-run average beta of 0.5 relative vs. the MSCI All Country World Index, while the eVestment Median Liquid Market Fund, a proxy for public equity strategies, has had a long-run average beta of 0.9. Note: Cambridge Associates’ database utilizes the quarterly unaudited and annual audited fund financial statements produced by the fund managers (GPs) for their Limited Partners (LPs). These documents are provided to Cambridge Associates by the fund managers themselves. Calculations are based on data compiled from 2,193 private equity funds.

Source: Cambridge Associates, eVestment, Bloomberg, KKR, 2019.

 

Whereas the current beta embedded in public markets’ capitalization is by definition skewed toward past winners, we believe today’s private equity deal counts are more indicative of future prospects. Investors around the world have taken notice. That’s likely one reason the recent growth of private equity assets under management has been so rapid, not only in North America and Europe, but also in the Asia-Pacific region, now home to a quarter of the world’s private equity market.⁵

The illiquidity premium—the reward investors earn for bearing the risk of holding assets that can’t be easily traded—represents a meaningful prospective source of private equity alpha. It may be an attractive feature to institutional investors with long-dated liabilities, such as insurers and pension plans. The largest U.S.-based investor in private equity, a public pension plan in California, isn’t satisfied with its existing allocation to the asset class. “We need private equity, we need more of it, and we need it now,” according to its chief investment officer.³ Even if private equity isn’t poised to match its past results, many investors still view it as the most promising asset class on offer today. In fact, 95% of a representative sample of 400 institutional investors surveyed in the United States plan to either increase or maintain their long-term allocations to the asset class.³

Private equity investors plan to increase or maintain their allocations

Institutional investors’ private equity long-term allocation plans, 2018
Institutional investors’ private equity long-term allocation plans, 2018 This chart shows that institutional investors with exposure to private equity overwhelmingly plan to either maintain their existing allocations to the asset class or increase their allocations. Only 5% of institutions surveyed plan to decrease their allocations.

Source: Cerulli, 2019.

 

Flexibility and patience can be additional sources of alpha for private equity investors who carefully choose portfolio companies offering the potential of multiple ways to win, and being able to pivot as developments warrant can prove highly valuable. Characteristics of promising investment opportunities may include companies with:

  • High-quality management teams
  • Strong recurring revenues and organic earnings growth in an industry enjoying structural tailwinds
  • Businesses that operate in industries with strong barriers to entry
  • Low capital intensity
  • High operating leverage—the ability for each incremental dollar of revenue to flow through as fully as possible to the bottom line, with margins expanding along with the scale of business

While these characteristics are good indicators of a successful business, overbidding for such traits is an ever-present pitfall. If a private equity sponsor pays too much for its portfolio companies, it may struggle to create value for investors. Consequently, it makes sense to look for managers who have good judgment about the inherent value of a particular business and extensive experience executing strategies that would make the business more profitable—and, by extension, more valuable.

Private equity’s public relations problem

Although the industry is maturing, we continue to see private equity participants get criticized for behaviors that were more prevalent during the industry’s infancy, evoking a popular narrative rife with corporate raiders, hostile takeovers, and junk bond-financed mergers and acquisitions. Barbarians at the Gate (1989), Den of Thieves (1992), and The Predators’ Ball (1988), and other books relayed the most egregious examples of the day’s dubious practices.

In the late 1980s and early 1990s, many industry firms spearheaded deals by contributing equity capital representing only 10% to 20% of the entire enterprise value, borrowing the rest of the funds required to close the transaction. This left many private equity-backed companies overleveraged and with little financial flexibility to weather a downturn in the economic cycle. The business failures, bankruptcy filings, and personnel reductions that inevitably followed continue to haunt the industry’s reputation today.

Private equity has come a long way since then. Rather than relying on abrupt practices, such as asset stripping and employee layoffs, to cut costs and turn a quick profit, private equity investing has become more focused on driving growth, improving competitive positioning, and focusing on sustainable, long-term value creation. We’re seeing many portfolio companies scaling their businesses, executing thoughtful merger-and-acquisition plans to drive top-line growth, and generating value where it didn’t exist before. In our experience, the more recent reality debunks the popular narrative of frequent bankruptcies, unmet pension obligations, and job destruction—stories of high-profile deals gone awry that marked private equity’s early days. Further, in the current climate, it’s not uncommon for owners to contribute 40%, 50%, or even 60% of the total enterprise value of an acquired business in their own equity capital, which lessens the need for borrowed money and increases the financial flexibility of a firm to negotiate the next recession, whenever it arrives.

“In many ways, private equity has become a driver of efficient, responsible, and sustainable capital allocation, helping investors, companies, and their communities.”

A growing force for building corporate value

Our experience provides a counterpoint to the negative private equity narrative. In many ways, private equity has become a driver of efficient, responsible, and sustainable capital allocation, helping investors, companies, and their communities. While this may be oversimplifying the ways in which private equity firms add value to portfolio companies, we’ve observed countless examples in each of the following generic strategies that have created value for investors in private equity funds.

First institutional capital may work well in the current environment

Investors vs. fund managers: views on private equity pricing, 2018¹¹
Institutional investors vs. fund managers: views on private equity pricing, 2018 This chart shows that the majority of private equity fund managers and institutional investors agree that private equity valuations are reasonably high, based on a representative survey of 400 professional and institutional investors in the United States.

Source: Cerulli, 2019.

 

  1. First institutional capital—Many successful business founder-owners eventually find their personal wealth concentrated in the equity of their own businesses, and they often want to diversify their net worth without forfeiting their involvement in what they’ve worked so hard to create. In addition, this concentration of considerable wealth in a single asset can lead the owner-manager to adopt a posture of risk avoidance that hampers further growth.  For example, opportunities to expand into a new geography or launch a new product line are dismissed because they’re perceived as uncertain. These owner-managers may be gifted entrepreneurs who build something out of nothing, but it takes a different set of skills and experience to take a mature business to the next level. At a certain point they need liquidity, wealth diversification, expertise, and partnership to allow them to continue investing in the future. For them, selecting the right buyer is as important as getting the price right. For private equity firms that can build rapport with the owner and describe an attractive plan for further wealth creation, there is an opportunity to acquire a good asset at a reasonable price. In addition, many of these businesses offer the proverbial low hanging fruit: clear value-creation opportunities that have been neglected or underappreciated by the founder. When owners are obsessed with not losing what they have, it’s hard for them to think about growing their businesses. These types of situations can work well for private equity investors and founder-owners alike, particularly in today’s market, where valuations are reasonably high.
  2. Buy-and-build strategies—A growing contingent of private equity funds has been contending with higher deal multiples—good if you’re selling but not good if you’re buying—through what’s known as a buy-and-build approach, “an explicit strategy for building value by using a well-positioned platform company to make at least four sequential add-on acquisitions of smaller companies.”⁵ A fund purchases a promising company and builds it to scale through the acquisition of a series of smaller, cheaper companies within the same industry or in a related industry. Since smaller companies tend to change hands with lower earnings multiples than larger companies do, a buy-and-build strategy allows the fund to capture the multiple arbitrage—buying businesses at relatively low multiples and integrating them into a larger organization with increased operating leverage that merits a higher multiple. However, the integration risks are real, and investors sometimes underestimate them. Very few private equity firms get high marks in the nuanced art of marrying divergent corporate cultures into a unified whole.
  3. Good-to-great approach—As the private equity markets have grown, it’s not uncommon to see the sale of a business from one sponsor to another. Industry observers sometimes wonder about the advisability of this for the buyer; if the business was professionalized and grown by the selling private equity firm, what value remains to be captured by the buying private equity firm? Sponsor-to-sponsor transactions aren’t inherently riskier, provided that the buyer has a credible value-creation plan for the business and plans to improve upon the gains made by the seller. The buyer takes a good business and makes it great by adding to the company’s capabilities.  This can take many forms, such as expanding internationally, upgrading management systems, and tapping top-grade managerial talent. This strategy isn’t only carried out though sponsor-to-sponsor transactions, it can also apply to buying a truly strong founder-owned business or a business acquired in a corporate carve-out transaction.
  4. Scratch-and-dent opportunities—Attractive private equity targets aren’t always perfect; sometimes they’re businesses with something that’s broken or complex, which causes the business to trade at a meaningful discount to its potential value. Firms that can repair these businesses and remove the elements of complexity can own a business that comes out the other end of this process displaying stronger growth and improved valuation metrics. Executing this strategy requires the right types of operating talent to make fundamental, often disruptive, changes to the portfolio company’s operations. These turnarounds can be difficult, but the rewards for success can be considerable. In an extreme example, one private equity firm was provided with an opportunity to acquire a broken business in a corporate carve-out transaction. The corporate seller found itself losing millions of dollars per year and could not identify a way to return the business to profitability. Ultimately, the corporate seller paid the private equity sponsor to take it off the seller’s hands. After executing on a series of identified initiatives and strategic acquisition, the private equity firm was able to return the company to profitability, representing a unique case of what we would call scratch-and-dent investing.
  5. Distressed-for-control investing—Distressed-for-control investing involves exchanging the debt securities of a target business for equity securities in the same company—generally a controlling ownership position. This form of value investing can be rewarding when a fundamentally sound business becomes overleveraged to the point that it can’t meet its current obligations. Sometimes what’s broken in a business can impair its balance sheet, with loan defaults resulting from an unexpected change in the global business environment. An investor in a distressed enterprise has the opportunity to earn an attractive return while rescuing a business that may be on the brink of extinction. A capital-structure-agnostic view helps in these special situations. Private equity investors that have the agility to pursue opportunities across the capital structure can enjoy outsize gains if they select the right part of the capital structure of the right company at the right time. However, this strategy has risks that can’t be taken lightly. It takes years of experience, for example, to understand which securities will control the restructuring, whether or not the debt securities can be exchanged for a controlling position, and, most importantly, to know what to do with the business once you own it. 

Conclusion

Today, private equity helps align the interests of owners and management, helps the capital markets operate more efficiently, and spurs productivity growth. Private equity continues to evolve and provide an incubator for ideas that lead to accelerated business growth, new ways to finance businesses, and employment growth—big thinking that contributes to better living standards more broadly. Private equity investing can continue to build this momentum as a growing force for good and play a positive role in the years ahead, contributing to the collective betterment of an interconnected web of company owners, managers, employees, pensioners, and communities throughout the global economy.

Connecticut Tries Again to Legalize Adult-Use Cannabis

Connecticut Gov. Ned Lamont has renewed his push for cannabis legalization this year, and while advocates say the concept of legalization has support in the legislature, Lamont’s proposed bill will likely require more work on the granular details before it has the support it needs to pass both chambers.

Lamont called for legalization during last year’s legislative session, as well, and although lawmakers worked on three separate bills to legalize and regulate adult-use cannabis, the session ended without any of the legislation advancing to the governor’s desk.

Lamont announced this year’s renewed push for legalization during his State of the State address in February. He then worked alongside the chairmen of key legislative committees to draft comprehensive legislation that would not only legalize cannabis for adults 21 and older, but also support the social and criminal justice components of legalization.

Senate and House leadership ultimately introduced S.B. 16 to realize the governor’s goals.

The legislation would legalize the possession of up to 1.5 ounces of cannabis starting July 1, and in July 2022, the state would launch retail cannabis sales.

Continue reading at Cannabis Business Times

Cannabis Industry: 2020 Predictions

Cannabis sales have increased substantially in the last few years, but so has the competition with more growers, retailers and other entrepreneurs vying for a stake in the “green rush.” At the same time, an oversupply of marijuana and the cost of operating in this highly regulated industry are taking their toll.

Here, industry executives predict top trends for 2020.

Cannabis Legalization Is Going Global

Legalization is growing outside of the United States, and countries that are first to the global marketplace can create sustainable advantages for themselves in their customer base and their funding. Kyle Detwiler, chief executive of Clever Leaves, an international operator with brands, extraction facilities, cultivation operations, and other investments in six countries, says that countries like Colombia and Portugal that have been among the first to legalize cannabis “are poised to continue establishing their global dominance in short order.”

The countries’ first-mover status will also be a magnet for financial interest he said. “There is little doubt that the expanding European cannabis market will make it an attractive investment opportunity,” Detwiler said.

Hemp, the source for CBD in many non-psychoactive products, will expand internationally as well, driven by the CBD’s demand. The CBD market will grow to $2.1 billion in consumer sales by 2020 according to the Hemp Business Journal, with $450 million of those sales coming from hemp-based sources. Puerto Rico’s Department of Agriculture has already reported there will be at least 10,000 acres of hemp cultivated for commercial purposes in 2020.

Read More Here at Forbes

Canopy Growth Announces David Klein as New Chief Executive Officer

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) announced that effective January 14, 2020, David Klein has been appointed as the Company’s Chief Executive Officer.

David brings a wealth of expertise to this role, having served in a number of senior leadership capacities over the past 14 years at Constellation Brands. His capabilities include extensive CPG and beverage alcohol industry experience, strong financial orientation, and experience operating in highly regulated markets in the U.S., Canada, Mexico and Europe. David is an experienced strategist with a deep understanding of how to build enduring consumer brands while leveraging operational scale across a dispersed production footprint. He is a strong leader with a proven track record of developing diverse and high performing teams.

In his current role as executive vice president and chief financial officer at Constellation Brands, David oversees all aspects of the company’s finance operations, all mergers and acquisitions, as well as the company’s information technology function. He is widely respected among members of the U.S. investment community, earning recognition as a top CFO by Institutional Investor magazine the past three years. David serves as a member of Constellation Brands’ executive management committee. He has served on the Canopy Growth Board of Directors for over a year and is presently Canopy Growth’s Board Chair. This familiarity with the Company’s current leadership team and strategy will allow David to integrate quickly, a major benefit in the fast-moving cannabis sector.

“Canopy Growth sits at the forefront of one of the most exciting new market opportunities in our lifetime,” said Klein. “Thanks to the efforts of Mark and the entire team at Canopy Growth, no company is better positioned to win in the emerging cannabis market. I look forward to working with the team to build on the foundation that has been laid, to develop brands that strongly resonate with consumers, and to capture the market opportunity before us. Together we will drive sustainable, industry-leading growth that benefits employees, shareholders and the communities in which we operate.”

The appointment of David Klein follows a thorough recruitment process overseen by a special Hiring Committee of the Board using global recruitment company Heidrick & Struggles, which saw a wide variety of exceptional candidates vetted and interviewed. David will step down from all other positions he currently holds, remaining a member of the Canopy Board of Directors. The Company intends to appoint a new Chairperson upon David’s effective date as CEO.

Consistent with the previously announced transition plan, with a new CEO identified Mark Zekulin will be stepping down from his role as CEO and resigning his seat on the Board of Directors of Canopy effective December 20, 2019.  As a founding employee of Canopy Growth (then Tweed Marijuana Inc.), Mark was instrumental in building Canopy into what it is today first in the role of President, then President and Co-CEO, and finally as CEO.

“It has been an incredible six years at Canopy Growth, and I have witnessed the team and Company grow from five people in an abandoned chocolate factory, to thousands of people across five continents,” said Zekulin. “Canopy today is positioned to win with the resources, infrastructure, team, and award-winning culture needed to succeed. It has truly been an honour to be part of building a unique, Canadian success story like Canopy, and I look forward to seeing the Company continue to evolve and grow under David’s leadership.”

Here’s to Future Growth.

About Canopy Growth Corporation
Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

error

Enjoy this blog? Please spread the word :)